Malaria News and Research

Latest Malaria News and Research

Financial Times examines product development partnerships developing drugs for neglected diseases

The Financial Times examines the rise of product development partnerships (PDPs), which are "non-governmental organizations that generate their own funding and build partnerships with universities, businesses, government and patients in low-income countries to develop new drugs, vaccines, prevention techniques and diagnostics for diseases such as tuberculosis, HIV, malaria, cholera and meningitis."

22 Jul 2011

WHO warning increases opportunity for Biomagnetics urine based TB assay

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced that the World Health Organization ("WHO") on Sunday July 17, 2011 warned that the widely used blood tests to detect tuberculosis ("TB") are unreliable and "dangerous" to patients because they produce too many false negatives and positives.

21 Jul 2011

Shah discusses importance of partnerships in global health

The Malaria Policy Center's "Malaria Watch" blog describes comments made by USAID Administrator Rajiv Shah during a recent global health community call. During the call, Shah "stressed that to solve global health issues there needs to be shared 'responsibility across all partners.' Partnerships help 'save money, and saving money can save lives,'" the blog notes.

20 Jul 2011

Papua New Guinea government stepping down as Global Fund grant principal recipient

Following an audit last year by the Global Fund to Fight AIDS, Tuberculosis and Malaria that found Papua New Guinea's National Department of Health (NDOH) "had not complied with grant guidelines and some $7 million had been misdirected," the government is stepping down as the principal recipient (PR) of Global Fund grants in order to "improve its response," IRIN reports.

20 Jul 2011

DNDi's new drug development programme for children with HIV/AIDS

Today at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, the Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV/AIDS.

19 Jul 2011

Anti-malaria drug provides key insight into potential treatments for autoimmune diseases

In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers.

19 Jul 2011

Washington Post examines access to maternal and child health care in Sierra Leone

The Washington Post examines access to maternal and child health services in Sierra Leone after the government dropped fees for such services last year, a move that "appears to have sharply cut into mortality rates for pregnant women and deaths from malaria for small children."

18 Jul 2011

Researchers closer to developing meningitis B vaccine

"New research may bring scientists one step closer to developing a vaccine that protects against hundreds of strains of meningococcus B, the most common cause of bacterial meningitis," according to research published last week in Science Translational Medicine, HealthDay News reports.

18 Jul 2011

Disrupting protein components kills mosquitoes

Mosquitoes die soon after a blood meal if certain protein components are experimentally disrupted, a team of biochemists at the University of Arizona has discovered.

18 Jul 2011

SEEK HIV-v vaccine demonstrates 90% reduction in HIV viral load

SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.

18 Jul 2011

Inovio reports strong immune responses with VGX-3100 vaccine for cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of T cell immune responses of up to over two years (at the latest time measured) in 7 of 8 evaluated patients following a fourth vaccination of VGX-3100, its investigational SynCon® DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus (HPV) that is delivered using intramuscular electroporation.

15 Jul 2011

Simple steps can improve malaria prevention

Megan Fotheringham, a public health adviser with the President's Malaria Initiative, describes in a post on USAID's "IMPACTblog" how a program in Kenya worked to improve the successful administration of malaria prevention therapy among pregnant women in the country's Gem District simply by sending to antenatal clinics a memo describing when to administer the treatment.

15 Jul 2011

Malaria prevention project using dirty sock odor awarded Grand Challenges grant

The odor of dirty socks can be used to attract mosquitoes and kill them before they're able to spread malaria, Fredros Okumu of the Ifakara Health Institute in Tanzania said on Wednesday, Agence France-Presse reports.

14 Jul 2011

Positive data from Inovio's VGX-3400X Phase I study against H5N1 influenza

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.

14 Jul 2011

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that patient dosing has begun in the AdV HALT Trial (A Randomized, Placebo-Controlled, Multi-site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation [HSCT]).

14 Jul 2011

Gates Foundation's Grand Challenges Explorations increases investments in bold innovative ideas

The Bill & Melinda Gates Foundation today announced that twelve grantees have advanced to the next level of Grand Challenges Explorations (GCE), an initiative that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges. The grantees will receive additional funding to continue Phase II of their research over a two-year period.

13 Jul 2011

Malaria parasite uses antibody camouflage to hide

Scientists from Rigshospitalet - Copenhagen University Hospital - and the University of Copenhagen have discovered malaria parasites use a type of antibody camouflage to hide from the immune system in the placentas of pregnant women, according to research published in the Proceedings of the National Academy of Sciences, a University of Copenhagen press release states.

13 Jul 2011

Donors should continue to provide AIDS funding to China, UNAIDS head says

Cutting AIDS funding to China will "be a big mistake for a donor and particularly, for anyone who's invested in China today, ... for the simple reason that this funding is a catalytic fund," UNAIDS Executive Director Michel Sidibe told Reuters in an interview on Monday.

13 Jul 2011

New innovative device can eliminate malaria

Grand Challenges Canada announces a grant today to support further development of a new innovative device to attract and kill mosquitoes that can transmit malaria.

13 Jul 2011

BRICS health ministers agree to improve access to low-cost medicines

Health ministers from Brazil, Russia, India, China, and South Africa in Beijing "on Monday vowed to improve access to low-cost and high-quality medicine - and called on developed nations to shoulder responsibility in helping the poor," Agence France-Presse reports.

13 Jul 2011